- €343.73m
- €267.37m
- €300.42m
- 100
- 54
- 46
- 77
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 232 | 248 | 235 | 263 | 300 |
Cost of Revenue | |||||
Gross Profit | 232 | 248 | 235 | 263 | 300 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 209 | 226 | 217 | 241 | 271 |
Operating Profit | 23 | 22.4 | 17.8 | 21.9 | 29.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.1 | 22.2 | 17.3 | 21.6 | 29.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.3 | 13.2 | 9.63 | 14.4 | 21.3 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 15.1 | 12.9 | 9.41 | 13.7 | 20.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 15.3 | 12.9 | 9.43 | 13.7 | 20.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.29 | 1.94 | 1.4 | 2 | 2.93 |
Dividends per Share |